science wire

« BACK

Pharmacology



Results 251 - 300 of 2145.


Health - Pharmacology - 16.07.2020
Trial to explore more effective treatments for seriously ill COVID-19 patients
A major trial is underway to explore how artificial intelligence can be used to develop more effective treatments for very ill COVID-19 patients.

Health - Pharmacology - 16.07.2020
Potential treatment for rare degenerative disease
Potential treatment for rare degenerative disease
Yale pharmacology professor Barbara Ehrlich and her team have uncovered a mechanism driving a rare, lethal disease called Wolfram Syndrome and also a potential treatment.

Life Sciences - Pharmacology - 16.07.2020
Erasing memories to stop drug relapse
Removing memories associated with morphine use from the brains of mice enables Stanford researchers to prevent relapse and could point to a new approach for treating the opioid epidemic.

Health - Pharmacology - 16.07.2020
For early treatment of mild COVID-19, University of Minnesota trial shows hydroxychloroquine has no benefit over placebo
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the early treatment of mild COVID-19 among persons who are not hospitalized.  The trial results, published in the Annals of Internal Medicine , determined that hydroxychloroquine did not decrease the severity of COVID-19 symptoms over 14 days any better than a placebo.

Health - Pharmacology - 15.07.2020
Drones to Deliver Tuberculosis Drugs in Madagascar
Drones to Deliver Tuberculosis Drugs in Madagascar
The use of drones in global health settings has rapidly evolved in the past years. As drone technology continues to expand beyond the military and recreational sectors, it is foreseen that it will have a significant role to play in healthcare delivery.

Pharmacology - Psychology - 15.07.2020
You can see it in their eyes: Traumatic experiences leave mark on pupils
The pupils of people with post-traumatic stress disorder respond differently to those without the condition when they look at emotional images, a new study has found. The study looked for traces of traumatic events in the eyes of patients with PTSD, which can occur following a distressing event and causes greater sensitivity, or hyperarousal, to everyday events and an inability to switch off and relax.

Health - Pharmacology - 15.07.2020
UofG to play key role in new study into COVID-19 long-term health impacts
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched. The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care.

Research Management - Pharmacology - 14.07.2020

Pharmacology - Health - 13.07.2020

Pharmacology - Health - 13.07.2020
Secret defence against adenoviruses
Secret defence against adenoviruses
Study shows: Arsenic trioxide strengthens the body's defenses against viruses An adenovirus infection can be potentially life-threatening, especially for children after a stem cell transplant.

Health - Pharmacology - 13.07.2020
Drug that calms 'cytokine storm' linked to lower risk of death among COVID-19 patients on ventilators
Drug that calms ’cytokine storm’ linked to lower risk of death among COVID-19 patients on ventilators
Share on: Share on Twitter Share on Facebook Share on LinkedIn Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, compared with those who didn't receive the drug, according to a new University of Michigan study.

Pharmacology - Health - 13.07.2020
New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia A
Second interim analysis of the STASEY study, including data from 193 patients, consistent with results from phase III HAVEN studies, with no new safety signals identified 1,2,3 STASEY is the largest

Health - Pharmacology - 10.07.2020
Caltech Professor Answers Community’s Questions on Coronavirus
At a Glance Leadership President Provost Board of Trustees Legacy History & Milestones Historic Awards & Honors Caltech Archives Interactive History Map News Publications This is Caltech Calt

Health - Pharmacology - 10.07.2020
Helping track and reduce COVID-19 infections in Northeast Brazil
A combination of thermal drones, artificial intelligence and mathematical modelling is helping scientists track and reduce the spread of COVID-19 in Northeast Brazil: one of a series of innovative coronavirus research initiatives being carried out by UCL and scientists in Brazil.

Health - Pharmacology - 10.07.2020
Cystic fibrosis drug trialled to fight inflammation caused by COVID-19
Patients with COVID-19 will be given the cystic fibrosis drug 'Dornase alfa' to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.

Health - Pharmacology - 09.07.2020

Health - Pharmacology - 08.07.2020
From lung scarring to heart damage, COVID-19 may leave lingering marks
A preventive medicine specialist receives Saccharin spray during contamination suit testing at the Coronavirus Surge Facility in Philadelphia.

Social Sciences - Pharmacology - 08.07.2020
New guidance launched to help people from Punjabi community with alcohol problems
The authors' recommendations provide a framework for supporting people from other communities with alcohol problems who are not engaging with existing services.

Health - Pharmacology - 07.07.2020
UChicago molecular engineers take innovative approaches to COVID-19 vaccine
As scientists around the world rush to learn more about COVID-19, several labs at the University of Chicago's Pritzker School of Molecular Engineering are taking an innovative approach to vaccine development.

Health - Pharmacology - 06.07.2020
"We have the here and now. That’s all we really have."
Acceptance and Commitment Therapy (ACT) is still a relatively young approach from behavioral therapy, but has already proven itself in the treatment of a wide range of mental disorders.

Pharmacology - 03.07.2020
Over the counter anti-inflammatory drugs could be damaging the health of runners
Anti-inflammatory drugs, such as over-the-counter ibuprofen, are commonly used by runners to ease post-exercise aches, pains or injuries, but carry a risk of harm according to a new study into the use of the pain killers by recreational runners in the UK. Non-steroidal anti-inflammatories (NSAIDs) block the production of inflammatory chemicals called prostaglandins, which reduces pain and inflammation, however they also block protective prostaglandins in the stomach and prostaglandins that help maintain kidney function.

Life Sciences - Pharmacology - 01.07.2020
Unit analyses causes of male infertility
Unit analyses causes of male infertility
In what is a great success for the Faculty of Medicine at the University of Münster, the Clinical Research Unit "Male Germ Cells" will continue to receive funding - amounting to 5.7 million euros - from the German Research Foundation (DFG).

Health - Pharmacology - 30.06.2020
Meeting challenges through basic research
Meeting challenges through basic research
Many scientists are currently undertaking work on the Sars-CoV-2 virus. But hundreds of projects supported by the SNSF are already contributing to finding answers to the current health crisis. In Switzerland and around the world, the novel coronavirus has become a priority for scientific research. Projects supported by the Swiss National Science Foundation (SNSF) are no exception.

Health - Pharmacology - 29.06.2020
Transplant patient recovers from COVID-19 after receiving donated plasma
UChicago Medicine's use of plasma from COVID-19 survivors believed to be first-of-its-kind procedure A year after his successful lung transplant, Edgardo Diaz, 30, found himself back in the hospital with COVID-19.

Pharmacology - Health - 29.06.2020
New artificial heart valve could transform open-heart surgery
New artificial heart valve could transform open-heart surgery
A new type of artificial heart valve, made of long-lived polymers, could mean that millions of patients with diseased heart valves will no longer require lifelong blood-thinning medication after valve replacement surgery. These impressive results show the PoliValve is a promising alternative for valve replacement surgery Geoff Moggridge The valve, called PoliValve, has been developed by scientists at the Universities of Cambridge and Bristol.

Health - Pharmacology - 29.06.2020
Children at risk from falling UK vaccination rates, warn doctors
Children risk becoming 'unseen victims of the COVID-19 pandemic', with evidence suggesting they may be missing routine vaccinations, warn researchers.

Pharmacology - Health - 26.06.2020
Novartis Cosentyx gains positive CHMP opinion for pediatric psoriasis, reinforcing established efficacy and safety profile
EMA CHMP positive opinion paves way for Cosentyx to become a first-line systemic treatment in pediatric psoriasis   CHMP opinion based on two Phase III studies showing Cosentyx provides fast and stro

Pharmacology - Health - 26.06.2020
Novartis receives positive CHMP opinion for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps
If approved, Xolair (omalizumab) will provide patients who have severe chronic rhinosinusitis with nasal polyps, not adequately controlled by intranasal corticosteroids, with the first anti-immunoglo

Health - Pharmacology - 25.06.2020
Learning from the history of vaccines, disease
Learning from the history of vaccines, disease
In a graduate seminar taught by Stanford medical anthropologist S. Lochlann Jain, students examined how previous epidemics - such as yellow fever, smallpox, polio and AIDS - can illuminate the social dynamics and politics of the era.

Pharmacology - Health - 25.06.2020
Hydroxychloroquine shortages: when the enthusiasm for a potential cure affects patients
Amid initial public and scientific optimism for hydroxychloroquine (HCQ) as a potential treatment for COVID-19, health care professionals raised concerns about shortages of this inexpensive drug, which is widely used in the treatment of several rheumatic diseases such as arthritis.

Health - Pharmacology - 24.06.2020
UW-Madison and UW Health quickly launch a number of COVID-19 clinical trials
As the outbreak of the novel coronavirus that causes COVID-19 was deemed a pandemic, research institutions across the United States rapidly shifted focus to studies aimed at understanding the virus and finding treatments.

Health - Pharmacology - 24.06.2020

Health - Pharmacology - 24.06.2020
Extracts of the Plant A. annua are Active Against SARS-CoV-2
Extracts of the Plant A. annua are Active Against SARS-CoV-2
Cooperation between scientists from the Max Planck Institute, University of Kentucky and Freie Universität Berlin No 107/2020 from Jun 24, 2020 Chemists at the Max Planck Institute of Colloids and In

Health - Pharmacology - 23.06.2020
Parliamentarians hear of 'high chance' of coronavirus vaccine
Parliamentarians hear of ’high chance’ of coronavirus vaccine
Two of Imperial's leading coronavirus experts gave evidence to the House of Lords about their research to tackle COVID-19 Professor Robin Shattock, who is developing a vaccine for COVID-19 and Profes

Health - Pharmacology - 23.06.2020
First volunteer receives Imperial COVID-19 vaccine
The first healthy volunteer has now received a candidate coronavirus vaccine developed by researchers. The clinical team, who delivered a small dose of the vaccine to the participant at a West London facility, are closely monitoring the participant and report they are in good health, with no safety concerns.

Health - Pharmacology - 23.06.2020
Breast Cancer Diagnostics: Spin-off Artidis announces successful clinical trial
Breast Cancer Diagnostics: Spin-off Artidis announces successful clinical trial
The company Artidis, a University of Basel spin-off, has announced that it developed a test procedure that can detect breast cancer with a very high sensitivity. This is demonstrated by a clinical trial that investigated whether a nanomechanical biomarker of tissue samples is suitable for the diagnosis of breast cancer.

Pharmacology - Health - 23.06.2020
Global deal follows UQ superbug drug discoveries
Global deal follows UQ superbug drug discoveries
Antibiotics discovered at The University of Queensland will be fast-tracked under a $A16 million international research deal.

Health - Pharmacology - 22.06.2020
Computational pharmacology to combat the coronavirus
The ongoing COVID-19 pandemic has hit the world population hard, spreading throughout the globe since the beginning of the year and claiming more than 450,000 victims. The entire scientific community is engaged in an unprecedented effort to curb the progression of the disease, for which no specific cure is yet available.

This site uses cookies and analysis tools to improve the usability of the site. More information. |